We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Show more
CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance with Nasdaq for continued...
CAMBRIDGE, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) today announced the successful completion of a comprehensive financial...
CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) and Factor Bioscience Limited (“Factor”) today announced an exclusive...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.19 | -17.4311926606 | 1.09 | 1.46 | 0.835 | 25297 | 1.00092604 | CS |
4 | -0.2 | -18.1818181818 | 1.1 | 1.46 | 0.8349 | 32787 | 1.01724124 | CS |
12 | -0.96 | -51.6129032258 | 1.86 | 1.92 | 0.8349 | 35196 | 1.13687554 | CS |
26 | -1.45 | -61.7021276596 | 2.35 | 2.625 | 0.8349 | 20486 | 1.30030082 | CS |
52 | -0.23 | -20.3539823009 | 1.13 | 2.625 | 0.8349 | 20790 | 1.43242343 | CS |
156 | -3.3 | -78.5714285714 | 4.2 | 7.15 | 0.8349 | 33450 | 3.39223536 | CS |
260 | -3.3 | -78.5714285714 | 4.2 | 7.15 | 0.8349 | 33450 | 3.39223536 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions